甲状旁腺癌合并1型神经纤维瘤病

Noriaki Hayashibara, Toshihisa Ogawa, E. Tsuji, Mariko Oya, A. Fujii
{"title":"甲状旁腺癌合并1型神经纤维瘤病","authors":"Noriaki Hayashibara, Toshihisa Ogawa, E. Tsuji, Mariko Oya, A. Fujii","doi":"10.4172/2324-9110.1000170","DOIUrl":null,"url":null,"abstract":"Neurofibromatosis type 1 is a genetic disorder resulting from a mutation in the NF1 gene, and is known to have an association with hyperparathyroidism that is caused by parathyroid adenoma in almost all cases. Parathyroid carcinoma in neurofibromatosis type 1 is extremely rare. Among the reports of neurofibromatosis type 1 with comorbid hyperparathyroidism have been a patient with coincident pheochromocytoma and medullary thyroid cancer, and a patient with a mutation of the RET gene, the causative gene of multiple endocrine neoplasia (MEN). These cases suggest an association between neurofibromatosis type 1 and multiple endocrine tumors, but the detailed mechanism is still unknown. Moreover, a mutation in the HRPT2 gene has been noted as a genetic cause of parathyroid carcinoma, but at presents no genetic link between neurofibromatosis type 1 and a mutation in the HRPT2 gene has been demonstrated, and the association between neurofibromatosis type 1 and parathyroid cancer remains unclear. We have reported an extremely rare case of neurofibromatosis type 1 with coincident hyperparathyroidism that is caused by parathyroid carcinoma.","PeriodicalId":73658,"journal":{"name":"Journal of clinical & experimental oncology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2016-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":"{\"title\":\"Parathyroid Carcinoma Coincident With Neurofibromatosis Type 1\",\"authors\":\"Noriaki Hayashibara, Toshihisa Ogawa, E. Tsuji, Mariko Oya, A. Fujii\",\"doi\":\"10.4172/2324-9110.1000170\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Neurofibromatosis type 1 is a genetic disorder resulting from a mutation in the NF1 gene, and is known to have an association with hyperparathyroidism that is caused by parathyroid adenoma in almost all cases. Parathyroid carcinoma in neurofibromatosis type 1 is extremely rare. Among the reports of neurofibromatosis type 1 with comorbid hyperparathyroidism have been a patient with coincident pheochromocytoma and medullary thyroid cancer, and a patient with a mutation of the RET gene, the causative gene of multiple endocrine neoplasia (MEN). These cases suggest an association between neurofibromatosis type 1 and multiple endocrine tumors, but the detailed mechanism is still unknown. Moreover, a mutation in the HRPT2 gene has been noted as a genetic cause of parathyroid carcinoma, but at presents no genetic link between neurofibromatosis type 1 and a mutation in the HRPT2 gene has been demonstrated, and the association between neurofibromatosis type 1 and parathyroid cancer remains unclear. We have reported an extremely rare case of neurofibromatosis type 1 with coincident hyperparathyroidism that is caused by parathyroid carcinoma.\",\"PeriodicalId\":73658,\"journal\":{\"name\":\"Journal of clinical & experimental oncology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-12-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of clinical & experimental oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4172/2324-9110.1000170\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of clinical & experimental oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2324-9110.1000170","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6

摘要

1型神经纤维瘤病是一种由NF1基因突变引起的遗传性疾病,已知几乎所有病例都与甲状旁腺瘤引起的甲状旁腺功能亢进有关。1型神经纤维瘤病的甲状旁腺癌极为罕见。在1型神经纤维瘤病合并甲状旁腺功能亢进的报道中,有1例合并嗜铬细胞瘤和甲状腺髓样癌的患者,1例多发内分泌瘤(multiple endocrine neoplasia, MEN)的致病基因RET基因突变的患者。这些病例提示1型神经纤维瘤病与多发性内分泌肿瘤之间存在关联,但具体机制尚不清楚。此外,HRPT2基因突变已被认为是甲状旁腺癌的遗传原因,但目前尚未证实1型神经纤维瘤病与HRPT2基因突变之间存在遗传联系,1型神经纤维瘤病与甲状旁腺癌之间的关系尚不清楚。我们报告了一例极为罕见的1型神经纤维瘤病合并甲状旁腺功能亢进是由甲状旁腺癌引起的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Parathyroid Carcinoma Coincident With Neurofibromatosis Type 1
Neurofibromatosis type 1 is a genetic disorder resulting from a mutation in the NF1 gene, and is known to have an association with hyperparathyroidism that is caused by parathyroid adenoma in almost all cases. Parathyroid carcinoma in neurofibromatosis type 1 is extremely rare. Among the reports of neurofibromatosis type 1 with comorbid hyperparathyroidism have been a patient with coincident pheochromocytoma and medullary thyroid cancer, and a patient with a mutation of the RET gene, the causative gene of multiple endocrine neoplasia (MEN). These cases suggest an association between neurofibromatosis type 1 and multiple endocrine tumors, but the detailed mechanism is still unknown. Moreover, a mutation in the HRPT2 gene has been noted as a genetic cause of parathyroid carcinoma, but at presents no genetic link between neurofibromatosis type 1 and a mutation in the HRPT2 gene has been demonstrated, and the association between neurofibromatosis type 1 and parathyroid cancer remains unclear. We have reported an extremely rare case of neurofibromatosis type 1 with coincident hyperparathyroidism that is caused by parathyroid carcinoma.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Influence of Long-term Abemaciclib, A New CDK 4/6 Inhibitor: Decrease in Liver Metastasis in a Patient Suffering from Metastatic Breast Cancer Monoclonal Antibodies Treatment Safe Combination of Cisplatinand Metformin Reverts theMalignant Ascites in a MouseModel to a Solid Tumor byDownregulation of ÎNp63 andInduces Tumor Dormancy via mTOR/ p21 Mechanism Hepatocellular CarcinomaPost Viral Hepatitis B and C:Application of the PrognosticScore of Singapore Iron Overload in the Setting of H63D Gene Mutation and Inrahepatic Cholangiocarcinoma
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1